PIPELINE

Pipeline

CATEGORY INDICATION DRUG CANDIDATE PRECLINICALPRECLI
NICAL
PHASE 1 PHASE 2 PHASE 3
Degenerative
Disease
Parkinson¡¯s
Disease
HSG4112
(Vutiglabridin)
Osteoarthritis HSG4112
(Vutiglabridin)
Metabolic
Disease
Obesity
(Partnership:
Daewon Pharm Co., Ltd.)
HSG4112
(Vutiglabridin)
Type 2
Diabetes
HGR4113
Animal
Health
Obesity HSG4112-R
(Vutiglabridin-R)